









Markets
/
Stocks
/
nasdaq-vrax
/

Virax Biolabs Group Ltd

VRAX

0.370USD

+0.020+5.69%

Close 12/24, 13:00（ET）Quotes delayed by 15 min

2.42MMarket Cap

LossP/E TTM



Virax Biolabs Group Ltd

0.370

+0.020+5.69%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

You can check out the annual or quarterly balance sheets of Virax Biolabs Group Ltd here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025H2

FY2025H1

FY2024H2

FY2024H1

FY2023H2

FY2023H1

FY2022Q4

FY2022Q2

Total equity

Cash, cash equivalents and short-term investments

17.82%4.23M

42.64%7.29M

-61.62%3.59M

11.77%5.11M

--9.35M

--4.57M

--21.76K

--11.68K

- Cash and cash equivalents

17.82%4.23M

42.64%7.29M

-61.62%3.59M

11.77%5.11M

--9.35M

--4.57M

--21.76K

--11.68K

Receivables

-85.93%30.65K

-85.74%26.16K

--217.84K

--183.36K

----

--0.00

-Accounts and notes receivable

----

--2.36K

----

--0.00

Inventory

56.79%94.67K

411.08%125.25K

--60.38K

--24.51K

--0.00

--20.95K

--21.07K

Prepaid expenses

5.19%539.38K

-9.08%595.93K

82.18%512.78K

-9.46%655.42K

--281.48K

--723.87K

--6.00K

--10.28K

Other current assets

----

--4.69K

----

Total current assets

11.72%4.89M

34.54%8.03M

-54.53%4.38M

12.69%5.97M

--9.63M

--5.30M

--48.71K

--43.03K

Non-current assets

Net Fixed Assets

38.92%1.53M

107.47%1.41M

--1.10M

--679.42K

----

-Fixed Assets

59.77%1.85M

127.99%1.59M

--1.16M

--695.27K

----

-Accumulated depreciation

479.24%317.83K

1007.25%175.56K

--54.87K

--15.86K

----

Goodwill and other intangible assets

----

-100.00%0.00

--374.67K

--178.40K

----

Total non-current assets

38.92%1.53M

33.73%1.41M

518.67%1.10M

--1.05M

--178.40K

----

Total assets

17.19%6.43M

34.41%9.44M

-44.11%5.48M

32.58%7.03M

--9.81M

--5.30M

--48.71K

--43.03K

Liabilities

Current liabilities

-Other payables

----

--0.00

--27.24K

--129.94K

--449.61K

Accrued expenses

--194.08K

40.66%303.92K

-100.00%0.00

-27.45%216.06K

--409.71K

--297.81K

----

--259.41K

Short-term debt and lease liabilities

78.21%85.46K

445.71%271.10K

-67.21%47.95K

-87.26%49.68K

--146.25K

--390.00K

----

--100.00K

-Short-term debt

--32.47K

--222.73K

-100.00%0.00

----

--146.25K

--390.00K

----

--100.00K

-Short-term lease liabilities

10.51%52.99K

-2.62%48.38K

--47.95K

--49.68K

----

Deferred liabilities

----

-100.00%0.00

----

--38.25K

----

Other current liabilities

----

-100.00%0.00

----

--38.25K

--27.24K

--129.94K

--449.61K

Total current liabilities

298.70%673.21K

-11.82%693.97K

-81.41%168.85K

-31.11%787.02K

--908.40K

--1.14M

--1.25M

--1.05M

Non-current liabilities

Long-term debt and lease liabilities

--0.00

Total non-current liabilities

65.33%291.54K

151.54%332.10K

--176.34K

--132.03K

----

Total liabilities

179.48%964.75K

11.64%1.03M

-62.00%345.19K

-19.56%919.05K

--908.40K

--1.14M

--1.25M

--1.05M

Shareholders' equity

Common equity

68.69%4.34K

139.62%4.34K

65.32%2.57K

55.40%1.81K

--1.56K

--1.17K

--999.00

--301.00

Retained earnings

4.05%5.58M

36.12%8.56M

-41.25%5.36M

43.25%6.29M

--9.13M

--4.39M

---973.78K

---742.33K

Gains losses not affecting retained earnings

5657.56%112.33K

86.82%82.71K

215.58%1.95K

1501.19%44.27K

---1.69K

--2.77K

---1.80K

---2.34K

Non-controlling interests

-2.63%-233.97K

-0.51%-228.12K

-2.51%-227.98K

4.14%-226.95K

---222.40K

---236.76K

---222.13K

---203.74K

Total equity

6.29%5.46M

37.84%8.42M

-42.29%5.14M

46.92%6.11M

--8.90M

--4.16M

---1.20M

---1.00M

Currency unit

USD

Audit opinions

FAQs

What is the balance sheet?



It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.

KeyAI

